2022 Hybrid Research Symposium Posters

The 2022 NETRF Hybrid Research Symposium poster session was held at the Boston meeting for presenters that attended in-person, however, all posters were viewable online through the virtual Symposium platform. 

Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.

Select Session
Name

Update on Incidence, Prevalence Treatment and Survival of Patients with Small bowel Neuroendocrine Neoplasms in The Netherlands

Presenter: Kaçmaz

Two novel DNMT1 inhibitors: 4′-Thio-2′-Deoxycytidine and 5’-aza-4′-Thio-2′-Deoxycytidine, for the treatment of MEN1 tumors in preclinical study.

Presenter: yuan

Trends and Disparities in Incidence and Survival Outcomes for Lung Neuroendocrine Tumors in California

Presenter: Mulvey

The Wnt signaling protein Dishevelled targets Somatostatin Receptor 2 for lysosomal degradation

Presenter: Carr

The impact of SARS CoV2 pandemic on PRRT in neuroendocrine patients: one year experience in an ENETS certified center

Presenter: Grana

Prostate Neuroendocrine Carcinoma – An Emerging Neuroendocrine Cancer with Unmet Need

Presenter: Fojo

Phase 1 study of Safety and Immunogenicity of a Survivin Long Peptide Vaccine (SurVaxM)

Presenter: Lyer

Peptide photosensitizer conjugates for implementation in GLP1R and SSTR targeted photodynamic therapy of neuroendocrine tumors

Presenter: Van Lith

Neuroendocrine Tumors in Young Adult Patients- Epidemiological Profile

Presenter: Fogassa

Nanotherapy targeting RHAMMB-positive pancreatic neuroendocrine tumors

Presenter: Du

Multiple endocrine neoplasia 4: genotype-phenotype association of germline CDKN1B variant type and site

Presenter: Halperin

Meaningful progress in the therapy of neuroendocrine cancers, needs rigorous interpretation of data and balanced trial designs

Presenter: Fojo

Loss of epigenetic repression of retrotransposons in pancreatic neuroendocrine tumors

Presenter: Senapati